Sees total revenue increasing by mid-to-high single-digit percentage. Sees core tax rate 18%-22%.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AZN:
- AstraZeneca reports Q4 core EPS $2.12, down 2% at CER
- AstraZeneca lifts earnings, advances pipeline and issues upbeat 2026 outlook
- AZN Earnings this Week: How Will it Perform?
- AstraZeneca price target raised to 11,500 GBp from 11,000 GBp at Deutsche Bank
- AstraZeneca’s TAPER Study Targets Simpler Severe Asthma Care With Tezepelumab